Pluristem shines in stem cell trial for muscle injury – FierceBiotech
FierceBiotechIsrael’s Pluristem Therapeutics ($PSTI) is back in the spotlight with some positive results for its stem cell therapy in treating patients with a muscle injury, giving the biotech some good news in its up-and-down development path. In the Phase I/II …Pluristem stem cell trial to treat muscle injury meets main goalReutersPluristem Gains Most in 17 … Continue reading
